Evidence map›Paper›PMID 42122198›Full record

ArticleCancers2026

Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

Asaad Trabolsi, Marianna Lekakis, Peter M Commisso, Nishant Gandhi, Andrew Elliott, Stephen V Liu, Patrick C Ma, Dave S B Hoon, Shuanzeng Wei, Emmanuel S Antonarakis and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Asaad TrabolsiSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0002-2479-1797
Marianna LekakisSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Peter M CommissoUniversity of Miami, Coral Gables, FL 33124, USA.
Nishant GandhiCaris Life Sciences, Phoenix, AZ 85040, USA.
Andrew ElliottCaris Life Sciences, Phoenix, AZ 85040, USA.ORCID 0000-0001-8494-8031
Stephen V LiuLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.
Patrick C MaLSU-LCMC Health Cancer Center, Louisiana State University Health Science Center, New Orlans, LA 70112, USA.
Dave S B HoonSt. John's Cancer Institute, Providence Healthcare Services, Santa Monica, CA 90404, USA.
Shuanzeng WeiFox Chase Cancer Center, Philadelphia, PA 19111, USA.
Emmanuel S AntonarakisMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA.ORCID 0000-0003-0031-9655
Artavazd ArumovSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0002-9520-2777
Jonathan H SchatzSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0003-1842-228X

Funding

Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel Bilbao · 2019 to 2026
$24.1M
NCI NIH HHS P30CA240139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ferroptosisimmune evasionTFR1TFRCtransferrin receptor

Identifiers

PMID42122198
PMCPMC13163038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.